Christopher Pazdan - 16 Mar 2026 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)

Role
Chief Operating Officer
Signature
/s/ Thomas Adams - Attorney-in-Fact
Issuer symbol
KRMD
Transactions as of
16 Mar 2026
Net transactions value
$0
Form type
4
Filing time
18 Mar 2026, 16:47:47 UTC
Previous filing
11 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pazdan Christopher Chief Operating Officer C/O KORU MEDICAL SYSTEMS, INC., 100 CORPORATE DRIVE, MAHWAH /s/ Thomas Adams - Attorney-in-Fact 18 Mar 2026 0002028813

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRMD Common Stock Options Exercise +5,064 $0.000000* 5,064 16 Mar 2026 Direct F1
transaction KRMD Common Stock Tax liability -1,628 -32% $4.28* 3,436 16 Mar 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRMD Restricted Stock Unit Award +31,226 $0.000000* 31,226 17 Mar 2026 Common Stock 31,226 Direct F3, F4
transaction KRMD Performance Stock Unit Award +31,226 $0.000000* 31,226 17 Mar 2026 Common Stock 31,226 Direct F3, F5
transaction KRMD Option to buy Common Stock Award +46,929 $0.000000* 46,929 17 Mar 2026 Common Stock 46,929 $4.35 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting.
F2 Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.
F3 Each unit represents a right to receive one share of common stock underlying the vested award on the applicable vesting date.
F4 This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 17, 2027 and each first, second and third anniversaries thereof (each, a vesting date).
F5 These units will vest based upon the achievement of certain performance conditions as of December 31, 2028. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved. These units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2028.

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.